| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/16/2004 | WO2004032963A3 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 12/16/2004 | WO2004023889A3 Full range nutritional supplements from plant materials and methods for their manufacture |
| 12/16/2004 | WO2004006848A3 Combination therapies with ftc for the treatment of hepatitis b virus infection |
| 12/16/2004 | WO2003082211A3 Synergy of dopamine d2 and adenosine a2 receptors activates pka signaling via beta/gamma dimers |
| 12/16/2004 | WO2003071922A3 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | WO2003015667A8 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254349 Mycobacterial antigens expressed under low oxygen tension |
| 12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
| 12/16/2004 | US20040254252 Tpoical applying a mixture containing alkoxybenzaldehyde compound |
| 12/16/2004 | US20040254238 Bone growth stimulation with NO/statin and other NO modulating combinations |
| 12/16/2004 | US20040254213 Use of bicyclo compounds for treating alzheimer's disease |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering |
| 12/16/2004 | US20040254172 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040254171 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040254170 Administering serotonine receptor antagonist; irritable bowel disorders |
| 12/16/2004 | US20040254169 Method of treating functional bowel disorders |
| 12/16/2004 | US20040254168 Irritable bowel disorders; serotonine receptor antagonist |
| 12/16/2004 | US20040254160 Benzothiazepine derivatives |
| 12/16/2004 | US20040254146 Carboxylate salts of galantamine and their pharmaceutical use |
| 12/16/2004 | US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 12/16/2004 | US20040254132 Ovary-specific genes and proteins |
| 12/16/2004 | US20040254125 Anthelmintic composition |
| 12/16/2004 | US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 12/16/2004 | US20040254097 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin |
| 12/16/2004 | US20040254096 Mucin synthesis inhibitors |
| 12/16/2004 | US20040254094 Antiproliferative agents for Dna virus |
| 12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253632 Identifying compounds that modulate an immune complex comprising lymphocyte receptor (TCR) and a major histocompatibility complex (MHC) antigen; immunodiagnostics; immunotherapy; high throughput assay; treating autoimmune and allergenic disorders |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253326 Composition for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | US20040253323 An aqueous alkali metal salt solution contains cesium and rubidium salt of chloride, sulfate, carbonate, phosphate, lactate, citrate, and acetate; antitumor agents, antiproliferative agents; inhibiting secretion of tumor proteases, increase pH to neutralize acidic hypoxic cancerous neoplasms |
| 12/16/2004 | US20040253322 Mixtures of clinoptilolite, plant extracts and vitamins, used for attenuation of neuropathic pain associated with diabetes or prevent deposition of immunoglobulin on axons |
| 12/16/2004 | US20040253320 A mixture of vitamins, minerals, simethicone for patients suffering inflammatory bowel disease; calcium carbonate, calcium sulphate; non-allergenic, improve absorption and side effect reduction |
| 12/16/2004 | US20040253319 Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253316 Production scale method of forming microparticles |
| 12/16/2004 | US20040253301 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 12/16/2004 | US20040253289 Natural plant compound with anti-HIV activity |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253229 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants |
| 12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
| 12/16/2004 | US20040253193 metronidazole and nystatin with a carrier; mouthwash |
| 12/16/2004 | DE202004015623U1 Lubricant, for use during sexual intercourse, incorporates a sexual stimulant which can also be used in a soap to give an arousal effect when washing |
| 12/16/2004 | DE10323759A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10317922A1 Combination preparation for preventing reduced bone growth during intake of oral contraceptive, comprises oral contraceptive and calcium and vitamin D preparations |
| 12/16/2004 | CA2528975A1 Therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhoea |
| 12/16/2004 | CA2528897A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | CA2528164A1 Solid preparation |
| 12/16/2004 | CA2528032A1 Methods and compounds for the treatment of vascular stenosis |
| 12/16/2004 | CA2527989A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars) |
| 12/16/2004 | CA2526792A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 12/16/2004 | CA2524381A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 12/16/2004 | CA2521682A1 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis |
| 12/15/2004 | EP1486208A1 Novel preventive for infections |
| 12/15/2004 | EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485476A2 Dimeric tf antagonist |
| 12/15/2004 | EP1485463A2 Lactobacillus strains |
| 12/15/2004 | EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications |
| 12/15/2004 | EP1485396A2 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 12/15/2004 | EP1485391A2 Phosphate transport inhibitors |
| 12/15/2004 | EP1485387A1 Carbamates as hiv protease inhibitors |
| 12/15/2004 | EP1485379A1 Beta 3-adrenergic receptor agonists |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485360A2 Sodium channel blockers |
| 12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485168A1 Combination of a cdk inhibitor and 5-fu for the treatment of cancer |
| 12/15/2004 | EP1485160A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 12/15/2004 | EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 12/15/2004 | EP1485131A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer |
| 12/15/2004 | EP1485127A2 Administration of agents for the treatment of inflammation |
| 12/15/2004 | EP1485118A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 12/15/2004 | EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 12/15/2004 | EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485090A2 Combinations comprising epothilone derivatives and alkylating agents |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes |
| 12/15/2004 | EP1485076A1 Therapeutic methods for acute myeloid leukemia |
| 12/15/2004 | EP1485074A2 Compositions for treating digestive functional pathologies |
| 12/15/2004 | EP1485064A2 Method for production of phytoalexins |
| 12/15/2004 | EP1485040A1 Method of administering an injectable antibiotic to the ear of an animal |